Bengaluru, India

Kirthana Mysore Vasudevarao Sindhe

This inventor holds 1 USPTO granted patent. Top assignee: Zumutor Biologics Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kirthana Mysore Vasudevarao Sindhe. Retrieved from https://idiyas.com/inventor/kirthana-mysore-vasudevarao-sindhe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 20.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kirthana Mysore Vasudevarao Sindhe: Innovator in Therapeutic Antibodies

Introduction

Kirthana Mysore Vasudevarao Sindhe is a notable inventor based in Bengaluru, India. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions for cancer treatment and other diseases.

Latest Patents

Kirthana holds a patent for "Antibodies that bind to c-type lectin domain family 2 member d (CLEC2D)." This patent relates to novel anti-CLEC2D antibodies and their compositions and methods of use. These antibodies are designed for therapeutic applications, as well as for prognostic and diagnostic purposes in various cancers and other diseases. She has 1 patent to her name.

Career Highlights

Kirthana is currently employed at Zumutor Biologics Inc., where she continues to advance her research in antibody development. Her work is pivotal in the ongoing fight against cancer and other serious health conditions.

Collaborations

Kirthana collaborates with talented professionals in her field, including her coworkers Bhagyashree Dikey and Kavitha Iyer Rodrigues. Their combined expertise enhances the innovative efforts at Zumutor Biologics Inc.

Conclusion

Kirthana Mysore Vasudevarao Sindhe is a pioneering inventor whose work in therapeutic antibodies is making a significant impact in the medical field. Her contributions are vital for advancing cancer treatment and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…